Showing 1 - 10 of 60
Markets for pharmaceuticals belong to the most intensly regulated markets. Manufacturers of pharmaceutical products frequently argue that regulatory interventions impede innovative activities. In this paper we scrutinize two important changes of the regulatory framework of the market for...
Persistent link: https://www.econbiz.de/10005677741
Persistent link: https://www.econbiz.de/10001999591
Persistent link: https://www.econbiz.de/10001859248
Persistent link: https://www.econbiz.de/10003320140
Persistent link: https://www.econbiz.de/10009951549
Persistent link: https://www.econbiz.de/10009951587
Persistent link: https://www.econbiz.de/10002173531
Persistent link: https://www.econbiz.de/10001544012
Persistent link: https://www.econbiz.de/10001373038
Persistent link: https://www.econbiz.de/10002073433